These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
959 related items for PubMed ID: 28506410
1. Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease. Dobrinja C, Santandrea G, Giacca M, Stenner E, Ruscio M, de Manzini N. Int J Surg; 2017 May; 41 Suppl 1():S26-S33. PubMed ID: 28506410 [Abstract] [Full Text] [Related]
2. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B. Clin Endocrinol (Oxf); 2007 Jun; 66(6):878-85. PubMed ID: 17437518 [Abstract] [Full Text] [Related]
3. Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging. Nehs MA, Ruan DT, Gawande AA, Moore FD, Cho NL. World J Surg; 2013 Jul; 37(7):1614-7. PubMed ID: 23519294 [Abstract] [Full Text] [Related]
7. Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism. Shawky M, Abdel Aziz T, Morley S, Beale T, Bomanji J, Soromani C, Lam F, Philips I, Matias M, Honour J, Smart J, Kurzawinski TR. Clin Endocrinol (Oxf); 2019 Feb; 90(2):277-284. PubMed ID: 30346646 [Abstract] [Full Text] [Related]
8. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Yano Y, Ito K. Endocr J; 2010 Feb; 57(11):953-8. PubMed ID: 20823623 [Abstract] [Full Text] [Related]
13. Use of a sestamibi-only approach to routine minimally invasive parathyroidectomy. Opoku-Boateng A, Bolton JS, Corsetti R, Brown RE, Oxner C, Fuhrman GM. Am Surg; 2013 Aug; 79(8):797-801. PubMed ID: 23896247 [Abstract] [Full Text] [Related]
14. Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism. Badii B, Staderini F, Foppa C, Tofani L, Skalamera I, Fiorenza G, Qirici E, Cianchi F, Perigli G. Head Neck; 2017 Feb; 39(2):241-246. PubMed ID: 27557453 [Abstract] [Full Text] [Related]
16. Targeted parathyroidectomy: effectiveness and intraoperative rapid-parathormone dynamics. Sadeghi N, Akin E, Lee JY, Roland J, Knoll S. Laryngoscope; 2008 Nov; 118(11):1997-2002. PubMed ID: 18849859 [Abstract] [Full Text] [Related]
17. Surgical treatment in patients with single and multiple gland primary hyperparathyroidism with the use of intraoperative parathyroid hormone monitoring: extensive single-center experience. Christoforides C, Vamvakidis K, Miliaras S, Tsoulfas G, Misichronis G, Goulis DG. Hormones (Athens); 2019 Sep; 18(3):273-279. PubMed ID: 31332766 [Abstract] [Full Text] [Related]
18. Intraoperative real-time (99m)Tc-sestamibi scintigraphy with miniature gamma camera allows minimally invasive parathyroidectomy without ioPTH determination in primary hyperparathyroidism. Cassinello N, Ortega J, Lledo S. Langenbecks Arch Surg; 2009 Sep; 394(5):869-74. PubMed ID: 19562365 [Abstract] [Full Text] [Related]
19. Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: A single institution experience. Mancilla EE, Levine MA, Adzick NS. J Pediatr Surg; 2017 Jan; 52(1):188-191. PubMed ID: 26898682 [Abstract] [Full Text] [Related]